Hyperliquid Strategies (NASDAQ:PURR) Trading Down 7.4% – Should You Sell?

Shares of Hyperliquid Strategies Inc (NASDAQ:PURR) were down 7.4% on Thursday . The stock traded as low as $9.07 and last traded at $9.0880. Approximately 8,268,294 shares changed hands during mid-day trading, an increase of 4% from the average session volume of 7,980,958 shares. The stock had previously closed at $9.81.

Analyst Ratings Changes

PURR has been the topic of several recent analyst reports. Weiss Ratings upgraded shares of Hyperliquid Strategies from a “sell (d)” rating to a “sell (d+)” rating in a research report on Wednesday, June 3rd. Cantor Fitzgerald upped their target price on shares of Hyperliquid Strategies from $6.00 to $8.00 and gave the stock an “overweight” rating in a research report on Monday, May 11th. Maxim Group assumed coverage on shares of Hyperliquid Strategies in a research note on Friday, April 24th. They set a “buy” rating and a $10.00 target price for the company. Chardan Capital reiterated a “buy” rating and issued a $9.75 price target on shares of Hyperliquid Strategies in a report on Friday, June 12th. Finally, Wall Street Zen upgraded shares of Hyperliquid Strategies to a “hold” rating in a research note on Saturday, February 21st. Three research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $9.25.

Hyperliquid Strategies Price Performance

The stock has a market capitalization of $1.31 billion, a P/E ratio of -1.23 and a beta of 1.64. The business’s 50 day moving average is $7.42.

Hyperliquid Strategies (NASDAQ:PURR) last released its quarterly earnings data on Thursday, May 7th. The company reported $1.01 earnings per share (EPS) for the quarter. The firm had revenue of $2.63 million during the quarter. As a group, equities analysts expect that Hyperliquid Strategies Inc will post 2.1 EPS for the current fiscal year.

Institutional Investors Weigh In On Hyperliquid Strategies

Several large investors have recently bought and sold shares of the business. Boothbay Fund Management LLC bought a new position in Hyperliquid Strategies during the fourth quarter valued at $40,000. XTX Topco Ltd bought a new stake in shares of Hyperliquid Strategies in the 4th quarter worth about $48,000. Squarepoint Ops LLC purchased a new stake in shares of Hyperliquid Strategies during the 4th quarter valued at about $73,000. Private Advisor Group LLC purchased a new stake in shares of Hyperliquid Strategies during the 1st quarter valued at about $83,000. Finally, Millennium Management LLC bought a new position in shares of Hyperliquid Strategies in the 4th quarter valued at about $87,000. Institutional investors own 9.45% of the company’s stock.

Hyperliquid Strategies Company Profile

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.